Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-26

FDA Approved: THEOPHYLLINE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approves Ajanta Pharma USA Inc.'s original ANDA for theophylline, a bronchodilator used to treat symptoms of asthma and chronic obstructive pulmonary diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Theophylline (Theophylline)

Snippet

ORIG AP for THEOPHYLLINE (THEOPHYLLINE)